losartan has been researched along with Nephrosis, Lipoid in 4 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Nephrosis, Lipoid: A kidney disease with no or minimal histological glomerular changes on light microscopy and with no immune deposits. It is characterized by lipid accumulation in the epithelial cells of KIDNEY TUBULES and in the URINE. Patients usually show NEPHROTIC SYNDROME indicating the presence of PROTEINURIA with accompanying EDEMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Proteinuria was decreased in groups MR and AR compared with group P (on day 14 after PAN administration, respectively; group P vs AR, P < 0." | 1.36 | Effects of mineralocorticoid and angiotensin II receptor blockers on proteinuria and glomerular podocyte protein expression in a model of minimal change nephrotic syndrome. ( Fujimoto, S; Fukuda, A; Iwatsubo, S; Kawachi, H; Kitamura, K, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fervenza, FC | 1 |
| Perazella, MA | 1 |
| Choi, MJ | 1 |
| Fukuda, A | 1 |
| Fujimoto, S | 1 |
| Iwatsubo, S | 1 |
| Kawachi, H | 1 |
| Kitamura, K | 1 |
| Nakahama, H | 1 |
| Sasaki, O | 1 |
| Yoshihara, F | 1 |
| Nakamura, S | 1 |
| Inenaga, T | 1 |
| Kawano, Y | 1 |
| Ueda, H | 1 |
| Kim, HJ | 1 |
| Ryu, JH | 1 |
| Han, SW | 1 |
| Park, IK | 1 |
| Paik, SS | 1 |
| Park, MH | 1 |
| Paik, DJ | 1 |
| Chung, HS | 1 |
| Kim, SW | 1 |
| Lee, JU | 1 |
4 other studies available for losartan and Nephrosis, Lipoid
| Article | Year |
|---|---|
American Society of Nephrology quiz and questionnaire 2013: glomerulonephritis.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Anti-Inflammatory Agents; Antibodies, Monoclonal, Mur | 2014 |
Effects of mineralocorticoid and angiotensin II receptor blockers on proteinuria and glomerular podocyte protein expression in a model of minimal change nephrotic syndrome.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Disease Models, Animal; Eplerenone | 2010 |
A favourable outcome using oral prednisolone and losartan only in a patient with ANCA-related glomerulonephritis: a discrepancy between histological activity and MPO-ANCA.
Topics: Administration, Oral; Aged; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Antihy | 2003 |
Combined therapy of cilazapril and losartan has no additive effects in ameliorating adriamycin-induced glomerulopathy.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pr | 2004 |